Overview
- Metz confirmed Monday that she is using a GLP-1 medication and has entered a partnership with Ro, a digital health company that prescribes and delivers these drugs by telehealth.
- She says the treatment has reduced constant preoccupation with food, improved stamina for her Broadway performances, eased inflammation and joint pain, and helped regulate her menstrual cycle.
- Metz did not reveal which specific GLP-1 she is taking or when she began treatment, and she stresses her account is a personal report rather than an independent clinical validation.
- She described a yearslong shift from skepticism to adoption after a friend’s research and concerns about her father’s obesity-related health, and she says she is combining the medication with strength training and medical oversight.
- GLP-1 drugs work by mimicking a gut hormone that curbs appetite and can change cravings, and their rising use through telehealth has prompted public debate about side effects, long-term safety, access, and social stigma.